Shiroiwa Takeru

シロイワタケル | Shiroiwa Takeru

Affiliation and department：
Job title： Chief Senior Researcher
Homepage URL (1)： https://linktr.ee/shiroiwa_takeru

Research field (5)： Healthcare management, medical sociology , Healthcare management, medical sociology , Medical equipment testing , Healthcare management, medical sociology , Clinical pharmacy

Research keywords (8)： preference-based measure , health policy , Health economics , health technology assessment , clinical research , quality of life research , cost-effectiveness analysis , health economic evaluation

Research theme for competitive and other funds (14)：

2024 - 2028 EQ-HWBのスコアリングアルゴリズムの開発と費用対効果評価への応用の検討
2022 - 2025 A study of medical futility - with special reference to the inclusion of economic futility
2021 - 2025 A study of psychological concepts that influence the formation of health state preferences
2021 - 2025 A study of psychological concepts that influence the formation of health state preferences
2020 - 2024 measurement and application of social care related quality of life as an outcome of integrated care

Show all

Papers (73)：

T. Shiroiwa, M. T. King, R. Norman, F. Müller, R. Campbell, G. Kemmler, T. Murata, K. Shimozuma, T. Fukuda. Japanese value set for the EORTC QLU-C10D: A multi-attribute utility instrument based on the EORTC QLQ-C30 cancer-specific quality-of-life questionnaire. Quality of Life Research. 2024
Takeru Shiroiwa, Takashi Fukuda. Are Web-Based Valuation Surveys for Preference-Based Measures as Reliable as Face-to-Face Surveys? TTO, DCE and DCE with Duration. Applied health economics and health policy. 2024. 22. 3. 391-400
Takeru Shiroiwa, Tatsunori Murata, Yasuhiro Morii, Eri Hoshino, Takashi Fukuda. Comparison of four value sets derived using different TTO and DCE approaches: application to the new region-specific PBM, AP-7D. Health and quality of life outcomes. 2024. 22. 1. 16-16
Yuta Suzuki, Keika Hoshi, Takeru Shiroiwa, Takashi Fukuda. Cost-effectiveness analysis of lifestyle interventions for preventing kidney disease in patients with type 2 diabetes. Clinical and experimental nephrology. 2023. 27. 9. 728-736
Naomi Akiyama, Tomoya Akiyama, Hideaki Sato, Takeru Shiroiwa, Mitsuo Kishi. Comparison of physicians' and dentists' incident reports in open data from the Japan Council for Quality Health Care: a mixed-method study. BMC oral health. 2023. 23. 1. 67-67

ｍore...

MISC (18)：

白岩健, 能登真一, 小林慎, 福田敬. CHEERS (Consolidated Health Economic Evaluation Reporting Standards) 2022詳細と解説 : ISPOR(国際医薬経済・アウトカム研究学会)CHEERS II Good Practicesタスクフォース報告書-Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 explanation and elaboration : A Report of the ISPOR CHEERS II Good Practices Task Force. 保健医療科学 = Journal of the National Institute of Public Health. 2023. 72. 4. 344-369
Noto S, Fukuda T, Saito S, Shimozuma K, Ikeda S, Shiroiwa T, Igarashi A, Ishida H, Moriwaki K, Kobayashi M. Preference-Based Health-Related Quality Of Life For Heart Disease Patients In Japan. Value in Health. 2018. 21. S31
Shiroiwa Takeru, Funagoshi Masaru, Murasawa Hideki, Shimozuma Kojiro, Saito Shinya, Fukuda Takashi. Explanation on the concept of mapping and MAPS statement. Journal of the National Institute of Public Health. 2018. 67. 4. 422-426
Noto S, Izumi R, Moriwaki K, Shiroiwa T, Igarashi A, Fukuda T, Ikeda S, Saito S, Shimozuma K, Ishida H, et al. Comparison Between Eq-5D And Hui In Japanese Population Norms. Value in Health. 2016. 19(7). A404
Fukuda T, Igarashi A, Ishida H, Ikeda S, Saito S, Sakamaki H, Shimozuma K, Shiroiwa T, Takura T, Tomita N, et al. Economic Evaluation Guideline For Pharmaceuticals And Medical Devices In Japan. Value in Health. 2016. 19(7). A832

ｍore...

Books (5)：

誰の健康が優先されるのか--医療資源の倫理学
岩波書店 2017 ISBN:4000612204
基礎から学ぶ医療経済評価
じほう 2014 ISBN:4840746567
ロスマンの疫学-科学的思考への誘い
篠原出版新社 2013 ISBN:4884123727
医療技術の経済評価と公共政策-海外の事例と日本の針路
じほう 2013 ISBN:4840743738
線形モデルとその拡張
株式会社シーエーシー 2011 ISBN:4990209737

Education (3)：

2005 - 2010 The University of Tokyo Graduate School of Pharmaceutical Sciences
2006 - 2007 National Institute of Public Health Biostatistics
2003 - 2005 The University of Tokyo Faculty of Pharmaceutical Sciences

Professional career (3)：

Ph.D. [pharmaceutical science] (the University of Tokyo)
MPH in biostatistics (National Institute of Public Health)
bachelor [pharmaceutical science] (the University of Tokyo)

Work history (7)：

2012/12 - 現在 Ministry of Health, Labour and Welfare Medical Economics Division, Health Insurance Bureau
2021/04 - National Institute of Public Health Center for Outcomes Research and Economic Evaluation for Health Chief Senior Researcher
2018/04 - 2021/03 National Institute of Public Health (NIPH) Center for Outcomes Research and Economic Evaluation for Health (C2H) Senior researcher
2014/04 - 2021/03 National Institute of Public Health Department of Health and Welfare Services Senior Researcher
2012/10 - 2014/03 National Institute of Public Health Center for Public Health Informatics Researcher

Show all

Association Membership(s) (8)：

International Society for Quality of Life Research , QOL/PRO研究会 , JAPANESE SOCIETY FOR PHARMACOEPIDEMIOLOGY , THE BIOMETRIC SOCIETY OF JAPAN , JAPAN SOCIETY FOR HEALTHCARE ADMINISTRATION , JAPAN HEALTH ECONOMICS ASSOCIATION , International Society For Pharmacoeconomics and Outcomes Research , International Society for Pharmacoeconomics and Outcomes Research

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page